265312-59-2 Usage
General Description
4-Benzothiazolamine,5-methoxy-2-methyl-(9CI) is a chemical compound with a molecular formula of C9H9NOS. It belongs to the class of compounds known as benzothiazoles, which are heterocyclic aromatic compounds containing a benzene ring fused to a thiazole ring. This specific compound is a derivative of benzothiazole, with a methyl group at the 2-position and a methoxy group at the 5-position. It is used in various chemical and pharmaceutical applications, including as a building block for the synthesis of other organic compounds. The compound has potential biological and pharmacological properties, and its structure and properties make it a subject of interest in medicinal chemistry research. However, further studies are needed to fully understand and explore its potential uses and effects.
Check Digit Verification of cas no
The CAS Registry Mumber 265312-59-2 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 2,6,5,3,1 and 2 respectively; the second part has 2 digits, 5 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 265312-59:
(8*2)+(7*6)+(6*5)+(5*3)+(4*1)+(3*2)+(2*5)+(1*9)=132
132 % 10 = 2
So 265312-59-2 is a valid CAS Registry Number.
265312-59-2Relevant articles and documents
Benzimidazole- and benzothiazole-quinones: Excellent substrates for NAD(P)H:quinone oxidoreductase 1
Newsome, Jeffery J.,Colucci, Marie A.,Hassani, Mary,Beall, Howard D.,Moody, Christopher J.
, p. 3665 - 3673 (2008/09/21)
A series of benzimidazole- and benzothiazole-quinones has been synthesized. The ability of these heterocyclic quinones to act as substrates for recombinant human NAD(P)H:quinone oxidoreductase (NQO1), a two-electron reductase upregulated in tumour cells,
5-Arylamino-2-methyl-4,7-dioxobenzothiazoles as inhibitors of cyclin-dependent kinase 4 and cytotoxic agents
Ryu, Chung-Kyu,Kang, Hye-Young,Lee, Sang Kook,Nam, Kyung Ae,Hong, Chang Yong,Ko, Won-Gil,Lee, Byung-Hoon
, p. 461 - 464 (2007/10/03)
5-Arylamino-2-methyl-4,7-dioxobenzothiazoles were synthesized as inhibitors of cyclin-dependent kinase 4 (CDK4) and cytotoxic agents. Most of the 4,7-dioxobenzothiazoles exhibited selective inhibitory activities for the CDK4 and cytotoxic potential agains
